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Abstract: The monodentate phosphane ligand 1,3,5-triaza-7-
phosphaadamantane (PTA) imparts excellent water solubility to
its complexes. We aimed to prepare precursors with one or
more PTA coligands for solubility and one or more labile ligands
for facile replacement by a linker. For this purpose, we investi-
gated the reactivity of the neutral isomers trans- and cis-
RuCl2(PTA)4 (1 and 2) towards 2,2′-bipyridine (bpy), as a model
chelating diimine linker. The new derivatives mer-
[Ru(bpy)Cl(PTA)3]Cl (9) and fac-[Ru(bpy)Cl(PTA)3]Cl (10) were
1. Introduction
The cagelike monodentate phosphane 1,3,5-triaza-7-phos-
phaadamantane (PTA), first reported in 1974 by Daigle and co-
workers,[1] is an amphiphilic, air-stable, neutral ligand, which is
soluble in several organic solvents and characterized by a high
solubility in water (ca. 235 g/L) by virtue of H bonding to the
tertiary amine nitrogen atoms. At moderately acidic pH (pKa =
5.89),[2] the regioselective protonation of one N atom generates
PTAH+. The coordination chemistry of PTA has been reviewed
thoroughly by Peruzzini and co-workers.[3] It typically binds
strongly to metal ions through the P atom in a monodentate
fashion. It has moderate steric demand (cone angle 103°), good
σ- and π-bonding abilities [comparable to those of P(OMe)3]
and, above all, it typically imparts excellent water solubility to
its complexes. By virtue of their solubility, PTA–metal complexes
have been investigated as homogeneous catalysts, either di-
rectly in aqueous solution or under aqueous–organic biphasic
conditions,[3–11] and as potential anticancer drugs.[8,12–17]
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prepared and characterized. We also found that PTA reacts rap-
idly with cis,fac-RuCl2(dmso-O)(dmso-S)3 (11) and trans-
RuCl2(dmso-S)4 (13) under mild conditions through the replace-
ment of pairs of mutually trans dmso ligands with high selectiv-
ity, even when in stoichiometric defect. Thus, 11 affords
cis,cis,trans-RuCl2(dmso-S)2(PTA)2 (12), whereas 13 gives 1. The
two dmso ligands of 12 can be replaced selectively by chelating
diimines such as bpy to afford the less symmetrical all-cis prod-
uct cis,cis-Ru(bpy)Cl2(PTA)2 (16).
Among these drug candidates, the most well-known are the
organometallic RAPTA-type compounds [RuCl2(η6-arene)(PTA)]
(RAPTA = ruthenium–arene PTA) developed by the group of
Dyson.[12]
We are particularly interested in the design and synthesis
of suitable RuII precursors for the preparation of water-soluble
ruthenium–porphyrin conjugates for investigation in the fields
of supramolecular chemistry[18] and photodynamic therapy.[19]
In this context, the leaving ligands in the ideal metal precursor
need to match, in terms of number and geometry, the binding
preferences of the bifunctional linker used to connect the por-
phyrin(s). Typically, in our case, the linker can be either a mono-
dentate pyridyl ring (such as in meso-pyridylporphyrins),[18] a
chelating diimine such as 4′-methyl-2,2′-bipyridine-4-carboxylic
acid (bpyAc, Figure 1)[19,20] or 2-(2′-pyridyl)pyrimidine-4-carb-
oxylic acid (cppH, Figure 1),[21,22] or a tridentate facial ligand
such as a functionalized 1,4,7-triazacyclononane (TACN).[23]
Figure 1. PTA (left) and the diimine linkers bpyAc (center) and cppH (right)
with proton numbering scheme.
Previously, we have largely exploited RuII–dmso (dmso = di-
methyl sulfoxide)[18,22,24] and RuII–[9]aneS3 precursors ([9]-
aneS3 = 1,4,7-trithiacyclononane).[19,21,25] Nevertheless, al-
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though most of them are well-behaved in terms of reactivity,
they did not provide sufficient solubility in water, which is a
highly desirable feature both in the design of efficient host mol-
ecules in supramolecular chemistry and in medicinal inorganic
chemistry. For this reason, we decided to investigate if the neu-
tral complexes trans- and cis-RuCl2(PTA)4 (1 and 2, respectively)
could be exploited as precursors for the preparation of water-
soluble conjugates. Even though these isomers and the ne-
glected RuIII complex trans-[RuCl4(PTAH)2]Cl (3) have been
known for many years[3,5,26,27] and have been used as catalysts
in several reactions (very often the isomer employed was not
specified),[3–7] their reactivity is largely unexplored. In this man-
uscript, we report a thorough investigation of the chemical be-
havior of the isomers 1 and 2 in water and other coordinating
solvents as well as their reactivity towards 2,2′-bipyridine (bpy),
which was used as a model for chelating diimine linkers (i.e.,
cppH and bpyAc). Such linkers might allow us to connect a
{RuClx(PTA)y} fragment (x = 0–2, y = 2–4, x + y = 4) to an appro-
priately functionalized porphyrin through the formation of an
amidic or esteric bond.[19,20] The new derivatives mer-
[Ru(bpy)Cl(PTA)3]Cl (9) and fac-[Ru(bpy)Cl(PTA)3]Cl (10) were
prepared and characterized.
In addition, we also investigated the reactivity of the well-
known RuIICl(dmso) complexes cis,fac-RuCl2(dmso-O)(dmso-S)3
(11) and trans-RuCl2(dmso-S)4 (13) towards PTA. An ideal pre-
cursor might have one or more PTA coligands for solubility and
one or more dmso ligands (with appropriate geometry) for fac-
ile replacement by the linker. We confirmed and expanded the
results originally reported by Kathó and co-workers on this
topic[11] and investigated the unexplored reactivity of the RuII
complex cis,cis,trans-RuCl2(dmso-S)2(PTA)2 (12) towards bpy and
bpyAc and obtained cis,cis-Ru(bpy)Cl2(PTA)2 (16) and cis,cis-
Ru(bpyAc)Cl2(PTA)2 (17, as a 50:50 mixture of the two stereoiso-
mers 17a and 17b).
2. Results and Discussion
2.1. trans-RuCl2(PTA)4 (1) and cis-RuCl2(PTA)4 (2)
The controversial story of the preparation and characterization
of the neutral isomers trans- and cis-RuCl2(PTA)4, which started
in 1992 with the report of Darensbourg and co-workers[5] and
was eventually concluded by Mebi and Frost 15 years later,[26]
has already been reviewed.[3] In short, 1 is the kinetic product
of the synthetic procedure from hydrated RuCl3 and it isomer-
izes to the thermodynamically stable cis isomer 2 in aqueous
solution. Later, Romerosa and co-workers established that light
can play an important role in the interconversion of the two
isomers.[27]
Scheme 1. Preparation of isomers 1 and 2.
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We prepared compound 1 as described in the literature
(Scheme 1).[5]
In an unsuccessful attempt to prepare the presumed RuIII
and RuII intermediates trans-[RuCl4(PTAH)2]Cl (3) and trans-
RuCl4(PTAH)2 (4), respectively, which had been occasionally iso-
lated in the recrystallization of 1,[5,28] we found that the reaction
between hydrated RuCl3 and PTA in ethanol also occurs at room
temperature, even though it is very slow (days) and affords low
yields of 1. The RuIII compound 3 was instead prepared select-
ively in high yield by a different route, that is, by the treatment
of the RuIII–dmso precursor [(dmso)2H]trans-[RuCl4(dmso-S)2]
with PTA in MeOH/HCl mixtures.[29]
In our hands, the best synthetic procedure for the prepara-
tion of 2 was the irradiation of an aqueous solution of 1 with
blue light (λ = 470 nm) for 1 h.[27] The evaporation of the sol-
vent afforded pure 2 quantitatively (according to NMR spectro-
scopy analysis). The isomerization of 1 could also be performed
thermally by heating an aqueous solution to reflux (1 h). How-
ever, the 31P NMR spectrum suggested that the thermal reac-
tion was not as clean as the photochemical one and led to the
formation of byproducts, including PTA oxide (PTAO),[1] charac-
terized by a sharp singlet at δ = –2.1 ppm in the 31P NMR
spectrum. With hydrated RuBr3 as a precursor and the same
synthetic procedures described above, we isolated the corre-
sponding and unprecedented bromo complexes trans-
RuBr2(PTA)4 and cis-RuBr2(PTA)4 in good yields and character-
ized them.[29]
A complete NMR spectroscopy characterization of 1 and 2 is
reported in Table 1. The 1H and 31P NMR spectra of 1 in CDCl3
are quite straightforward, owing to the high symmetry of the
complex. The 31P NMR spectrum of 2, consistent with the A2X2
spin system, presents two equally intense triplets at δ = –24.1
and –59.4 ppm (2JP,P = 28.6 Hz). On the basis of the spectrum
of 1 (Table 1) and literature data,[3] the most shielded triplet
was assigned to the pair of mutually trans PTA ligands. The
previously unreported 1H NMR spectrum of 2 in CDCl3 (contrary
to previous reports, 2 is considerably less soluble than 1 in this
solvent)[27] is more complex and consists of two relatively broad
singlets (12 H each) at δ = 4.04 and 4.47 ppm and a multiplet
(24 H) centered at δ = 4.48 ppm (Supporting Information, Fig-
ure S4). The singlets (or better, unresolved multiplets) belong
to the NCH2P groups of the two pairs of equivalent PTA ligands:
in the H–H COSY spectrum, they are both coupled to the multi-
plet (generated by the NCH2N groups), whereas in the hetero-
nuclear single quantum coherence (HSQC) spectrum (Figure S5)
they have distinct cross-peaks with carbon atoms that resonate
in the NCH2P region (Table 1). Thus, the 1H and 13C resonances
of the NCH2P groups are sensitive to the PTA position in the
complex. A 1H–31P HMBC spectrum (Figure S6) allowed us to
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Table 1. 1H, 13C, and 31P NMR chemical shifts δ [ppm] and coupling constants J [Hz] of 1, 2, and 2aq.
1H (J) 13C{1H} 31P{1H} (J) Solvent
trans-RuCl2(PTA)4 (1) 4.61, 4.57 (13.7), AB q, 24 H, NCH2N 73.3, NCH2N –50.6, s, mutually trans PTAs CDCl3
4.40, br. s, 24 H, NCH2P 53.1, NCH2P
cis-RuCl2(PTA)4 (2) 4.48, m, 24 H, NCH2N 73.1, NCH2N CDCl3
4.47, br. s, 12 H, NCH2P, mutually trans PTAs 54.0, NCH2P –59.4 (28.6), t, mutually trans PTAs
4.04, br. s, 12 H, NCH2P, PTA trans to Cl 58.7, NCH2P –24.1 (28.6), t, PTA trans to Cl
trans-RuCl2(PTA)4 (1) 4.63, br. s, 24 H, NCH2N 70.8, NCH2N –49.6, s, mutually trans PTAs D2O
4.35, br. s, 24 H, NCH2P 50.8, NCH2P
cis-RuCl2(PTA)4 (2) 4.65, m, 24 H, NCH2N n.d. –21.6 (28.5), t, PTA trans to Cl D2O[a]
4.47, br. s, 12 H, NCH2P, mutually trans PTAs –57.6 (28.5), t, mutually trans PTAs
cis-[RuCl(OH2)(PTA)4]+ (2aq) 4.59, m, 24 H, NCH2N 70.3, NCH2N –12.7 (30.3, 34.8), dt, PTA trans to OH2 D2O
4.26, d, 12 H, NCH2P 49.8, NCH2P –22.7 (26.1, 34.8), dt, PTA trans to Cl
4.11, s, 6 H, NCH2P 54.9, NCH2P –52.6 (26.1, 30.3), dd, mutually trans PTAs
3.97, s, 6 H NCH2P 54.6, NCH2P
[a] Recorded in the presence of ca. 1 M NaCl.
assign unambiguously the two NCH2P singlets in the 1H NMR
spectrum, which are pairwise related to the two triplets in the
31P dimension. The shielded singlet, which has a cross-peak
with the 31P triplet at δ = –24.1 ppm, was assigned to the PTA
ligands trans to Cl ligands, and the other was assigned to the
mutually trans PTA ligands.
We also reinvestigated the behavior of the two isomers in
aqueous solution. In agreement with published data,[27] 2
equilibrates rapidly with the monoaqua species cis-
[RuCl(OH2)(PTA)4]+ (2aq), which was isolated as a PF6– salt by
following another synthetic route (see below). The 31P NMR res-
onances of the mixture of 2 and 2aq were readily distinguished
in a P–P COSY spectrum (Figure S7). The integration of such
resonances afforded an equilibrium constant K = 1.39 × 10–2 M.
The 31P NMR spectrum of 2aq presents an AM2X spin system
(Table 1) with multiplets centered at δ = –12.7 (PTA trans to
OH2), –22.7 (PTA trans to Cl), and –52.6 ppm (mutually trans PTA
ligands). The assignments are consistent with the multiplicity
and intensity of each signal, as well as with the spectrum of 2
and literature data.[27] The 1H NMR spectrum of the mixture 2
and 2aq is quite complex. According to the 31P NMR spectrum,
pure 2 was obtained upon the addition of an excess of NaCl
(ca. 1 M) to the D2O solution. The previously unreported 1H
NMR spectrum of 2 in D2O (Table 1) is quite similar to that
recorded in CDCl3. The release of the second chlorido ligand
from 2aq and the formation of the diaqua species cis-
[Ru(OH2)2(PTA)4]2+ (5), which is characterized by two equally in-
tense triplets in the 31P NMR spectrum at δ = –16.0 (2JP,P =
27.1 Hz, PTA trans to OH2) and –45.9 ppm (mutually trans PTA
ligands), became apparent for concentrations of 2 below 5 mM.
This species was obtained previously upon the addition of an
excess of PTA to a solution of [Ru(OH2)6]2+.[2] The treatment of
an aqueous solution of 2 with 1 equiv. of AgCF3SO3 for 48 h at
room temperature afforded the triflate salt of 2aq, cis-
[RuCl(OH2)(PTA)4][CF3SO3], in moderate yield.[27] The chloride
abstraction was accompanied by the formation of Ag, Ag2O (the
AgCl precipitate was dark grey), or both. Attempts to remove
the second chlorido ligand from 2 by increasing the Ag+/Ru
ratio and to isolate the corresponding dicationic salt cis-
[Ru(OH2)2(PTA)4][CF3SO3]2 were unsuccessful.
Contrary to previous reports,[27] we found that a light-pro-
tected D2O solution of 1 is perfectly stable at room tempera-
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ture: the NMR spectra remained unchanged for days (Figure S3).
On the contrary, the exposure of the NMR tube to diffuse in-
door light induced the slow isomerization (days) of 1 to a mix-
ture of 2 and 2aq, as shown by the appearance of the corre-
sponding resonances in the 31P NMR spectrum.
We also investigated the thermal stability of 1 in the coordi-
nating solvents DMSO and CH3CN. When a concentrated solu-
tion of 1 in DMSO (in which the complex is only partially solu-
ble) was heated to 150 °C for 4 h, complete thermal isomeriza-
tion to the cis isomer 2 (which partially precipitates from the
warm solution) was observed. When the reaction was per-
formed at lower temperatures, a pale yellow solid was isolated
upon the addition of acetone. On the basis of the 31P NMR
spectrum, this precipitate is a mixture of 2 and an intermediate
characterized by an AX2 spin system: a triplet at δ = –25.6 ppm
is attributable to a PTA ligand trans to Cl, and a doublet at δ =
–61.0 ppm (2JP,P = 27.9 Hz) is in the region for mutually trans
PTA ligands (Figure S8). In addition to several PTA peaks, the
1H NMR spectrum shows a singlet at δ = 3.20 ppm, which is
attributable to a dmso-S ligand in a symmetrical environment
(equivalent methyl groups). On the basis of this spectral evi-
dence, the intermediate species was identified as cis,mer-
RuCl2(dmso-S)(PTA)3 (6, Figure 2). The intermediate 6 could not
be isolated in pure form: the highest 6/2 ratio (40:60, without
residual 1) was obtained by performing the reaction at 70 °C
for 1 h.
Figure 2. Intermediates isolated (not in pure form) when the thermal isomeri-
zation of 1 to 2 was performed in DMSO (6) or acetonitrile (7 and 8).
A similar behavior was observed when 1 was heated in
acetonitrile. In this case, the complex dissolves completely un-
der reflux conditions and a pale yellow solid precipitates spon-
taneously from the solution. On the basis of the 31P NMR spec-
trum (Figures S9–S10), the solid is a mixture of 2 (the amount
of which increases with the reflux time) and the two intermedi-
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ates 7 (major) and 8 (minor), both of which are characterized
by AX2 spin systems (Figure 2). On the basis of the chemical
shifts of the multiplets, the major intermediate 7 (triplet at δ =
–16.1 ppm, doublet at δ = –53.3 ppm, 2JP,P = 28.5 Hz) was iden-
tified as trans,mer-RuCl2(CH3CN)(PTA)3, whereas the minor one
(triplet at δ = –24.0 ppm, doublet at δ = –54.3 ppm, 2JP,P =
37.2 Hz) was identified as cis,mer-RuCl2(CH3CN)(PTA)3 (i.e., 8 is
the counterpart of 6 isolated in DMSO). In addition to the over-
lapped PTA resonances, the corresponding 1H NMR spectrum
consistently shows two singlets at δ = 2.30 and 2.46 ppm in
the same ratio as the resonances of 7 and 8 in the 31P NMR
spectrum, and these resonances are attributed to coordinated
CH3CN.
2.2. Reactivity of 1 and 2 towards bpy
Even though PTA binds strongly to RuII centers, the above-re-
ported results suggest that the replacement of at least one
chlorido ligand and one PTA ligand from isomers 1 and 2 seems
to be possible, depending on the solvent and reaction condi-
tions. Thus, we investigated the reactivity of 1 and 2 towards
bpy as a model for the diimine linkers bpyAc and cppH (Fig-
ure 1).
Both 1 and 2 reacted with bpy in water under reflux (under
light-free conditions), as evidenced by a progressive color
change of the solution from pale to deep yellow. More specifi-
cally, the treatment of 1 with 1 equiv. of bpy in water under
reflux (1 h), followed by the evaporation of the solvent, afforded
almost quantitatively the complex mer-[Ru(bpy)Cl(PTA)3]Cl (9,
Scheme 2).
Scheme 2. Preparation of mer-[Ru(bpy)Cl(PTA)3]Cl (9) upon the treatment of
1 with bpy in water under reflux.
Compound 9 was characterized by NMR spectroscopy and
mass spectrometry (as a PF6 salt, see the Experimental Section),
and its single-crystal X-ray structure was also determined (Fig-
ure 3). The 1H NMR spectrum (Figures S11–S14) shows eight
aromatic resonances, typical of bpy in an unsymmetrical envi-
ronment. In agreement with previous findings,[21,22] the most
deshielded doublet was assigned to 6-H, that is, the proton
with a partial positive charge that points towards the adjacent
chlorido ligand (Scheme 2). The PTA region of the spectrum
consists of two similar and partially overlapping sets of equally
intense signals, an AB quartet and a broad singlet, in a 1:2 ratio.
The most intense and upfield-shifted set was attributed to the
two equivalent trans PTA ligands, the protons of which fall in
the shielding cone of the adjacent bpy ligand. The HSQC spec-
trum established that the deshielded quartet in each set be-
longs to the NCH2N protons and that the singlet belongs to the
NCH2P protons. The 31P NMR spectrum (Figure S15) consists of
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an AX2 spin system: a triplet at δ = –30.2 ppm attributable to a
PTA trans to N, and doublet at δ = –47.6 ppm (2JP,P = 32.8 Hz)
for the mutually trans PTA ligands. The spectra did not change
upon the addition of NaCl; therefore, they can be safely attrib-
uted to the intact mer-[Ru(bpy)Cl(PTA)3]+ cation (see below). In-
terestingly, the crystals of 9 obtained upon the recrystallization
of the raw product from water/ethanol contain a network of
water molecules distributed in parallel rows along the [001] di-
rection, and these water molecules arguably contribute to the
cohesive energy of the crystal through hydrogen bonding to
the N atoms of the PTA moieties. The coordination distances
are in general agreement with the known trans influence of
the ligands: thus, the Ru–P bonds of the two trans PTA ligands
[2.3427(5) and 2.3275(5) Å] are slightly longer than the Ru–P
bonds trans to N [2.3018(5) Å], and the Ru–N bond trans to P
[2.1154(14) Å] is longer than that trans to Cl [2.0770(13) Å].
Figure 3. Molecular structure (50 % probability ellipsoids) of mer-
[Ru(bpy)Cl(PTA)3]Cl·6H2O (9).
The reaction between 2 and bpy is slower and less selective:
when a slight excess of bpy was used (bpy/Ru = 1.5), full con-
version required ca. 10 h of reflux. According to the NMR spec-
tra, the final mixture contained compound 9 as the main prod-
uct and another species identified as fac-[Ru(bpy)Cl(PTA)3]Cl
(10; 9/10 ≈ 10) in addition to some unidentified minor species
and PTAO. We found that an increase of the bpy/Ru ratio from
1.5 to 5, together with the addition of 1 equiv. of AgNO3, led
to the full conversion of 2 after 1 h of reflux. In addition, the
main product in this case was the fac isomer 10 (10/9 ≈ 7,
Scheme 3), which was obtained in pure form for unambiguous
characterization as the PF6 salt (10PF6, see Experimental Sec-
tion). An increase of the reaction time involved a progressive
decrease of the 10/9 ratio, which suggests that 10 is the kinetic
product of the reaction between 2 and bpy, whereas 9 is ther-
modynamically more stable.
Immediately after the dissolution of 10 in D2O, the 1H NMR
spectrum has only four aromatic resonances, in accord with a
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Scheme 3. Preparation of a mixture of the cationic isomers mer-[Ru(bpy)Cl(PTA)3]Cl (9) and fac-[Ru(bpy)Cl(PTA)3]Cl (10) upon the reaction of 2 with bpy in
water under reflux.
symmetrical coordination for bpy. However, a second set of four
bpy resonances, each one shifted slightly downfield with re-
spect to the parent one and attributed to the aqua species
fac-[Ru(bpy)(OH2)(PTA)3]2+ (10aq), grows slowly with time at the
expense of the original one (Figure S16). Equilibrium (10/10aq =
ca. 1.5) was reached within 24 h at room temperature. Consist-
ently, the 31P NMR spectrum shows two AX2 spin systems, at-
tributed (on the basis of their relative intensities and time evo-
lution) to 10 (triplet at δ = –24.3 ppm, PTA trans to Cl) and 10aq
(triplet at δ = –17.7 ppm, PTA trans to OH2; Figures S17 and
S18). The two doublets overlap almost completely at δ =
–44.2 ppm, that is, in the typical region for a PTA ligand trans
to a N atom (2JP,P = 29.2 Hz). The PTA region of the 1H NMR
spectrum is quite complicated owing to the overlapping reso-
nances of 10 and 10aq. It simplifies upon the addition of an
excess of NaCl (ca. 1 M), which reverts the equilibrium com-
pletely towards 10. Under these conditions, the spectrum is
similar to that of 9, but it is the less intense set of signals,
attributed to the PTA ligand trans to Cl, that is shielded by bpy
in this case. Taken together, the NMR features are totally con-
sistent with the proposed geometry. The single-crystal X-ray
diffraction data of crystals of the protonated derivative fac-
[Ru(bpy)Cl(PTAH)2.5(PTA)0.5][ClO4]3.5·2.5H2O, which was obtained
upon the addition of HClO4 to an aqueous solution of 10, al-
lowed us to confirm the geometry of the complex (Figure S41).
In conclusion, we found that the coordination of bpy to 1
and 2 in aqueous solution involves the replacement of one
chlorido ligand and one PTA ligand to afford the two isomers
9 and 10, depending on the conditions. Notably, the formation
of 10 was not observed in the reaction between 1 and bpy;
therefore, the mechanisms of the two substitution reactions are
different.
Consistent with these findings, the reactivity of both isomers
1 and 2 with bpy in organic solvents in which chloride release
is unfavorable (e.g., CH3CN and CHCl3) is much less pronounced
or altogether negligible. For example, no reaction was observed
between 2 and bpy in chloroform under reflux, whereas 1 re-
acted to a minor extent to afford (after 5 h) a complex mixture
of products that contained 2, 10, PTAO, and other minor un-
characterized species on the basis of the 31P NMR spectrum.
2.3. Reactions of RuII–dmso Complexes with PTA
After we started our work, we became aware that the reactivity
of cis,fac-RuCl2(dmso-O)(dmso-S)3 (11) towards PTA had been
investigated recently by Kathó and co-workers.[11] In good
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agreement with their results, we found that the treatment of
11 with PTA at room temperature leads selectively to the forma-
tion of cis,cis,trans-RuCl2(dmso-S)2(PTA)2 (12), regardless of the
nature of the solvent (e.g., in MeOH) or the PTA/Ru ratio
(Scheme 4). Even with less than 2 equiv. of PTA, compound 12
was obtained together with unreacted precursor. The replace-
ment of all dmso-S ligands (with the formation of a mixture of
1, 2, and 12) was observed when the reaction (PTA/Ru = 4) was
performed in MeOH under reflux. Conversely, we found that the
treatment of trans-RuCl2(dmso-S)4 (13, not investigated before)
with PTA at room temperature leads exclusively to 1
(Scheme 4). In this case, the nature of the product does not
depend on the PTA/Ru ratio employed. For example, when PTA/
Ru = 2, an approximately 1:1 mixture of 1 and unreacted pre-
cursor was recovered. No intermediate could be detected; this
suggests that the replacement of two trans dmso ligands by
two PTA ligands occurs rapidly and quantitatively. As already
mentioned (see above), the same behavior, that is, facile substi-
tution of two trans dmso-S ligands, was also observed with
[(dmso)2H]trans-[RuCl4(dmso-S)2] to afford 3.[29]
Scheme 4. Reactivity of cis,fac-RuCl2(dmso-O)(dmso-S)3 (11, top) and trans-
RuCl2(dmso-S)4 (13, bottom) towards PTA at room temperature.
The spectroscopic characterization of 12 (Figure S21) as well
as its X-ray structure (Figure 4) are in good agreement with
previous reports.[11,30]
Compound 12 is highly soluble in water, DMSO, CHCl3, and
CH2Cl2 and also soluble in warm MeOH and EtOH. We observed
that the 1H NMR spectrum of a light-protected D2O solution of
12 changes very slowly (days) at room temperature (Fig-
ure S20). As no signals for free DMSO or PTA were detected, the
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Figure 4. Molecular structure (50 % probability ellipsoids) of the two crystallo-
graphically independent units of cis,cis,trans-RuCl2(dmso-S)2(PTA)2 (12). Disor-
dered and underoccupied methanol and water crystallization molecules have
been omitted for clarity.
spectral changes were attributed to the progressive release of
a chlorido ligand to form the monoaqua species cis,cis,trans-
[RuCl(OH2)(dmso-S)2(PTA)2]+ (12aq). Consistent with this hypoth-
esis, a new singlet at δ = –53.0 ppm in the 31P NMR spectrum
grows slowly at the expense of the original one at δ =
–57.9 ppm (Figure S21). In the 1H NMR spectrum, in addition to
new signals in the PTA region, two new singlets for dmso-S
grow at δ = 3.37 and 3.41 ppm (i.e., very close to the original
singlet at δ = 3.38 ppm). In 12aq, although the two trans PTA
ligands are still equivalent, the two dimethyl sulfoxide ligands
are not.
We also investigated the possibility of obtaining complexes
with either five or six bound PTA moieties by using the cationic
RuII–dmso precursors cis,fac-[RuCl(dmso-O)2(dmso-S)3][PF6] (14)
and fac-[Ru(dmso-O)3(dmso-S)3][CF3SO3]2 (15), respectively. We
found that the treatment of 14 with 5 equiv. of PTA in methanol
at room temperature afforded cis-[RuCl(OH2)(PTA)4][PF6] (2aq) in
moderate yield. The 1H NMR spectrum of the complex in D2O
corresponds to that of 2aq observed in equilibrium with 2 (see
above) with an additional singlet for free MeOH (crystallization
molecule). The nature of the compound was also confirmed by
a low-quality X-ray structural determination (Figure S42). Re-
peated attempts to obtain better crystals were unsuccessful.
When the same reaction was performed at reflux temperature,
the precipitation of 2 occurred, and the resonances of 2aq, 5,
and PTAO were found in the 31P NMR spectrum of the mother
liquor (D2O). As there is no external chloride source, this finding
suggests that the disproportionation of 2aq into dichlorido (2)
and diaqua (5) {Ru(PTA)4} species occurs under these condi-
tions.
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Conversely, the treatment of 15 with 6 equiv. of PTA in meth-
anol or acetone at room temperature afforded no product, but
PTA was completely converted to PTAO within a few hours.
When the reaction was performed in chloroform under reflux
(no reaction occurred at room temperature), the observation of
the precipitation of 2 in moderate yield implies that chloride
abstraction from the solvent occurs. This finding suggests that
cationic RuII–PTA species have a very high chloride affinity.
Compound 12 has the characteristics of a good precursor
for the preparation of RuII–PTA derivatives, as it has the two
dmso-S ligands that, in principle, might be replaced relatively
easily by a chelating diimine. Indeed, we found that when 12
was treated with a slight excess of bpy in ethanol under reflux,
the original pale yellow solution became progressively ruby red.
A product of the same color, identified as cis,cis-Ru(bpy)Cl2-
(PTA)2 (16), was isolated in moderate-to-good yield (Scheme 5).
Scheme 5. Preparation of cis,cis-Ru(bpy)Cl2(PTA)2 (16) upon the treatment of
cis,cis,trans-RuCl2(dmso-S)2(PTA)2 (12) with bpy in ethanol under reflux.
Thus, the selective replacement of the two dimethyl sulfox-
ide ligands by bpy is accompanied by the concomitant isomeri-
zation to yield the less symmetrical all-cis product. Compound
16, which is highly soluble in water, chloroform, and DMSO and
moderately soluble in MeOH and EtOH, was characterized by
NMR spectroscopy and mass spectrometry, and its X-ray struc-
ture was determined (Figure 5).
Figure 5. Molecular structure (50 % probability ellipsoids) of cis,cis-
Ru(bpy)Cl2(PTA)2 (16). The three MeOH molecules of crystallization have been
omitted for clarity.
In the 1H NMR spectrum in CDCl3, bpy presents eight well-
resolved resonances (1 H each, Figure S24). As above, the most
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deshielded doublet was assigned to 6-H (Scheme 5). The two
inequivalent PTA ligands give four resolved resonances (6 H
each, Figure 6), which are pairwise coupled in the H–H COSY
spectrum (Figure S25). The two most upfield multiplets are at-
tributed to the PTA ligand trans to the Cl ligand that falls into
the shielding cone of the adjacent bpy ligand. The assignments
were confirmed by a 1H–31P HMBC spectrum.
Figure 6. 1H NMR spectrum (PTA region) of cis,cis-Ru(bpy)Cl2(PTA)2 (16) in
CDCl3. See the inset for the peak labels.
The 31P NMR spectrum of 16 in D2O (two doublets at δ =
–7.0 and –31.9 ppm, 2JP,P = 37.7 Hz) is similar to that of 16 in
CDCl3 (Figure S28). However, whereas the shielded resonance is
compatible with a P atom trans to a N atom, the other doublet
falls in the region for a PTA ligand trans to an O atom (see, for
example, the spectra of 2aq and 10aq) rather than trans to a Cl
ligand (expected at δ ≈ –15 ppm). Thus, we hypothesized that
16 in water undergoes rapid, quantitative, and selective release
of the Cl ligand trans to PTA to afford cis,cis-
[Ru(bpy)Cl(OH2)(PTA)2]+ (16aq, Scheme 6). This hypothesis is
consistent with the following: (1) the larger trans influence of
PTA compared with that of bpy, which is reflected by the solid-
state data, according to which the Ru–Cl bond trans to PTA
[2.4789(4) Å] is longer than that trans to bpy [2.4422(4) Å]; (2)
the downfield-shifted resonance of 6-H implies that the adja-
cent Cl ligand remains bound to the ruthenium center.
Scheme 6. Selective aquation of 16.
Scheme 7. Preparation of cis,cis-Ru(bpyAc)Cl2(PTA)2 (17) as a 50:50 mixture of the two stereoisomers 17a and 17b.
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Indeed, we found that the addition of aliquots of NaCl to the
D2O solution led to the progressive growth of a new set of
resonances in the NMR spectra, attributed to intact 16, at the
expense of the original ones, which are, thus, attributed unam-
biguously to 16aq. An intermediate situation in the 31P NMR
spectrum is shown in Figure 7 (see Figure S29 for the 1H NMR
spectrum). As expected, the chemical shift of the new de-
shielded doublet in the 31P NMR spectrum (δ = –12.7 ppm) is
now in the region compatible with a P atom trans to a Cl ligand.
The complete transformation of 16aq to 16 upon the addition
of excess NaCl (ca. 1 M) also induces a minor shift in the absorp-
tion maximum of the UV/Vis absorption spectrum from λ = 413
(16aq) to 418 nm (16, Figure S38).
Figure 7. 31P NMR spectrum of cis,cis-[Ru(bpy)Cl(OH2)(PTA)2]+ (16aq) in D2O
after the addition of an aliquot of NaCl (ca. 0.2 M) to afford a mixture of 16
and 16aq.
Similarly, the treatment of 12 with bpyAc in ethanol under
reflux afforded cis,cis-Ru(bpyAc)Cl2(PTA)2 (17) as a nearly 1:1
mixture of the two stereoisomers 17a (4-carboxylic acid trans
to PTA) and 17b (4-carboxylic acid trans to Cl, Scheme 7).
The spectroscopic features of 17a and 17b (Figures S30–S34)
are quite similar, except for the bpyAc resonances in the 1H
NMR spectrum, for which twelve well-resolved signals (1 H
each, six for each stereoisomer) were found in the aromatic
region, plus two methyl singlets (3H each). The most deshielded
doublet (δ = 9.58 ppm) was assigned to the 6-H proton in 17a
for the following reasons: (1) in free bpyAc, 6-H gives the most
deshielded resonance (δ = 8.87 ppm vs. 8.57 ppm for 6′-H); (ii)
in the complex, this proton is further deshielded by coordina-
tion and by the adjacent Cl ligand (see above). The second most
downfield doublet was assigned to 6′-H in 17b, in which it
points towards the adjacent Cl atom. All other bpyAc resonan-
ces were then unambiguously assigned on the basis of the 2D
H–H COSY and NOESY spectra. Particularly relevant were the
cross-peaks between the CH3 group (at the 4′-position) and the
3′-H singlets in the COSY spectrum and those between the sin-
glets of 3-H and 3′-H in the NOESY spectrum. As for 16, the
dissolution of 17 in water results in the release of the Cl ligand
trans to PTA to afford a mixture of 17aaq and 17baq, albeit at a
slower rate.
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3. Conclusions
In this manuscript, we reported a thorough investigation of the
neutral isomers trans- and cis-RuCl2(PTA)4 (1 and 2, respec-
tively), including their unprecedented comprehensive NMR
spectroscopy characterization (1H, 13C, and 31P) both in D2O
and in CDCl3 (Table 1).
The reactivity of 1 and 2 was basically unexplored. When
warmed in a coordinating solvent such as DMSO or acetonitrile,
the kinetic complex 1 isomerizes to the thermodynamically sta-
ble cis isomer 2, as it does in water. The neutral intermediates
cis,mer-RuCl2(dmso-S)(PTA)3 (6), trans,mer-RuCl2(CH3CN)(PTA)3
(7), and cis,mer-RuCl2(CH3CN)(PTA)3 (8) were isolated, albeit not
in pure form. Most interestingly, by virtue of these results, we
found that both 1 and 2 can be used as precursors of the
{RuCl(PTA)3}+ fragment. They react with chelating diimines such
as bpy in water under reflux through the selective replacement
of one chlorido ligand and one PTA ligand to afford the two
unprecedented isomeric derivatives mer-[Ru(bpy)Cl(PTA)3]Cl (9)
and fac-[Ru(bpy)Cl(PTA)3]Cl (10), depending on the conditions.
We are confident that the new insights provided by this work
on 1 and 2 will be valuable, in particular, for those interested
in the exploitation of these complexes and their derivatives as
catalysts.
We also investigated the reactivity of the RuII–dmso com-
plexes cis,fac-RuCl2(dmso-O)(dmso-S)3 (11), trans-RuCl2(dmso-
S)4 (13), cis,fac-[RuCl(dmso-O)2(dmso-S)3][PF6] (14), and fac-
[Ru(dmso-O)3(dmso-S)3][CF3SO3]2 (15) towards PTA. Expanding
the results reported by Kathó and co-workers,[11] we found that
PTA reacts rapidly with the neutral Ru–dmso precursors under
mild conditions through the replacement of pairs of mutually
trans dmso ligands with high selectivity. The replacement of
both dmso ligands also occurs when PTA is in stoichiometric
defect. Thus, 11 affords selectively cis,cis,trans-RuCl2(dmso-
S)2(PTA)2 (12), whereas 13 gives 1. In both cases, no intermedi-
ates could be isolated or even detected. Conversely, no new
cationic RuII–PTA complexes were obtained from 14 and 15. We
also found that the two dmso ligand of 12 can be replaced
selectively by chelating diimines such as bpy and bpyAc. Never-
theless, the substitution is accompanied by isomerization, and
the less symmetrical all-cis products cis,cis-Ru(bpy)Cl2(PTA)2 (16)
and cis,cis-Ru(bpyAc)Cl2(PTA)2 (17, as a 50:50 mixture of the two
stereoisomers 17a and 17b) were obtained. Thus, 12 is a prom-
ising precursor for the attachment of the highly water-solubiliz-
ing {RuCl2(PTA)2} fragment to bidentate linkers.
In general, as anticipated, all of the neutral Ru–PTA com-
plexes acquire the amphiphilic nature of PTA and are quite solu-
ble both in organic solvents (e.g., chloroform) and in water. Per-
haps counterintuitively, the solubility in water decreases upon
protonation of the coordinated PTA ligand to such an extent
that the addition of a strong mineral acid to an aqueous solu-
tion of a neutral Ru–PTA complex is often a convenient ap-
proach to obtain crystals of the corresponding charged PTAH
derivative.
Finally, we established that the 31P NMR resonance of a PTA
ligand bound to a RuII center is largely independent on the
solvent but is remarkably affected by the nature of the ligand
in the trans position and, thus, it can be used as a diagnostic
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tool to establish the geometry of octahedral Ru–PTA com-
plexes.[31] The typical chemical-shift regions as well as the corre-
sponding interval for the RuII–P bond lengths are reported in
Table 2. With the exception of the bis(hydride) complex cis-
RuH2(PTA)4,[26,32] there is a rough correlation between the two
parameters: as the Ru–P bond length increases, the 31P NMR
resonance shifts progressively to lower frequencies.
Table 2. Typical 31P NMR chemical-shift intervals (Δ) and Ru–P bond lengths
for PTA bound to octahedral RuII complexes as a function of the nature of
the trans ligand.
Ligand trans Δ 31P [ppm][a] Ru–P [Å] Reference
to PTA
OH2/OH –7 to –16 – this work, ref.[2]
Cl –20 to –26 2.232–2.283 this work, ref.[5b]
Br –24 to –27 2.266–2.281 ref.[29]
S[b] –30 to –45 2.280–2.318 ref.[13,21]
N[c] –34 to –50 2.260–2.344 this work, ref.[15b,33–37]
H –26.6[d] 2.299–2.300 ref.[26]
P[e] –50 to –60 2.290–2.400 this work, ref.[2,5b,11,14,26,28,29]
C[f] –68.4[d] 2.395(1) ref.[38]
[a] For comparison, the singlet of free PTA falls at δ = –98.2 ppm in D2O and
at δ = –102.3 ppm in CDCl3. [b] From [9]aneS3. [c] From imine or azole. [d]
Only one example. [e] From PTA. [f ] From cyclometalated 2-phenylpyridine.
Experimental Section
Materials: All chemicals were purchased from Sigma–Aldrich and
used as received. Solvents were of reagent grade. The precursors
trans-RuCl2(PTA)4 (1),[5] cis,fac-RuCl2(dmso-O)(dmso-S)3 (11),[39]
trans-RuCl2(dmso-S)4 (13),[39] cis,fac-[RuCl(dmso-O)2(dmso-S)3][PF6]
(14),[40] fac-[Ru(dmso-O)3(dmso-S)3](CF3SO3)2 (15),[41] and the ligand
bpyAc[42] were synthesized as described in the literature.
Instrumental Methods: 1D [1H (400 or 500 MHz), 13C (125.7 MHz),
and 31P (161 or 202 MHz)] and 2D (1H–1H COSY, 1H–13C HSQC, 31P–
31P COSY, 1H–31P HMBC, and 1H–1H NOESY) NMR spectra were re-
corded at room temperature with a JEOL Eclipse 400FT spectrome-
ter or a Varian 500 spectrometer. The 1H and 13C chemical shifts
were referenced to the peak of the residual non-deuterated solvent
(δ = 7.26 ppm and δ = 77.16 ppm for CDCl3) or measured relative
to the internal standard 4,4-dimethyl-4-silapentane-1-sulfonic acid
(DSS, δ = 0.00 ppm) for D2O. The 31P chemical shifts were measured
relative to external 85 % H3PO4 at δ = 0.00 ppm. The 1H–31P HMBC
spectra were recorded by using the standard sequence HMBCAD
with the Varian 500 spectrometer with a coupling constant (2J) of
5–10 Hz. The ESI mass spectra were collected in the positive mode
with a Perkin–Elmer APII spectrometer at 5600 eV. The UV/Vis spec-
tra were obtained with an Agilent Cary 60 spectrophotometer with
1.0 cm path-length quartz cuvettes (3.0 mL). The elemental analyses
were performed in the Department of Chemistry of the University
of Bologna. A home-made light-emitting diode (LED) apparatus, de-
scribed elsewhere,[29] was used for the photochemical reactions.
X-ray Diffraction: Data collections were performed at the X-ray
diffraction beamline (XRD1) of the Elettra Synchrotron of Trieste
(Italy).[43] Details are reported in the Supporting Information.[44–49]
Identification of the Complexes: For all complexes, the assign-
ment of 1H NMR PTA resonances was achieved through 1H–1H COSY
and 1H–13C HSQC 2D NMR spectroscopy (Supporting Information).
The assignment of the 31P NMR resonances was consistent with the
multiplicity and integration of the peaks as well as with the 31P–31P
COSY spectra.
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cis-RuCl2(PTA)4 (2): A procedure similar to that reported by Romer-
osa and co-workers,[27] that is, the photoisomerization of 1 in aque-
ous solution, was followed. Complex 1 (50.0 mg, 0.062 mmol) was
dissolved in water (5 mL) and irradiated with blue light (λ = 470 nm,
40 mW) for 1 h, during which the orange solution turned yellow.
The complete removal of the solvent by rotary evaporation afforded
pure 1 as a yellow solid (yield: 48.0 mg, 96 %). C24H48Cl2N12P4Ru
(800.57): calcd. C 36.01, H 6.04, N 20.99; found C 36.12, H 6.19, N
21.12. 1H NMR (D2O + NaCl): δ = 4.65 (m, 24 H, NCH2N), 4.47 (br. s,
12 H, NCH2P, mutually trans PTAs), 4.14 (br. s, 12 H, NCH2P, PTA trans
to Cl) ppm. 31P NMR (D2O + NaCl): δ = –21.6 (t, 2JP,P = 28.5 Hz, 2 P,
PTA trans to Cl), –57.6 (t, 2 P, mutually trans PTAs) ppm. 1H NMR
(CDCl3): δ = 4.48 (m, 24 H, NCH2N), 4.47 (br. s, 12 H, NCH2P, mutually
trans PTAs), 4.04 (br. s, 12 H, NCH2P, PTA trans to Cl) ppm. 13C NMR
(HSQC, CDCl3): δ = 73.1 (NCH2P), 58.7 (NCH2N mutually trans PTAs),
54.8 (NCH2P PTAs trans to Cl) ppm. 31P NMR (CDCl3): δ = –24.1 (t,
2JP,P = 28.6 Hz, 2 P, PTAs trans to Cl), –59.4 (t, 2 P, mutually trans
PTAs) ppm. ESI MS: m/z = 765.1 [M – Cl]+, 608.2 [M – Cl – PTA]+.
UV/Vis (CHCl3): λmax (ε, L mol–1 cm–1) = 344 (1022) nm.
cis-[RuCl(OH2)(PTA)4][PF6]·CH3OH (2aq): [RuCl(dmso)5][PF6]
(38.3 mg, 0.057 mmol) was dissolved in methanol (10 mL). PTA
(44.8 mg, 0.29 mmol, 5 equiv.) was added, and the solution was left
to stand overnight in the dark. Yellow crystals formed slowly from
the concentrated solution (5 mL). Some crystals were selected for
X-ray diffraction, and the others were collected by filtration, washed
with diethyl ether, and dried in vacuo (yield: 22.8 mg, 42 %).
C24H50ClF6N12OP5Ru·CH3OH (960.15): calcd. C 31.27, H 5.67, N 17.51;
found C 31.47, H 5.83, N 17.70. 1H NMR (D2O): δ = 4.59 (m, 24 H,
NCH2N), 4.26 (d, 12 H, NCH2P), 4.11 (s, 6 H, NCH2P), 3.97 (s, 6 H,
NCH2P), 3.34 ppm (s, 3 H, MeOH free). 31P NMR (D2O): δ = –12.7 (dt,
2JA,M = 30.3, 2JA,X = 34.8 Hz, 1 P, PTA trans to OH2), –22.7 (dt, 2JX,M =
26.1, 2JX,A = 34.8 Hz, 1 P, PTA trans to Cl), –52.6 (dd, 2JM,X = 26.1,
2JM,A = 30.3 Hz, 2 P, mutually trans PTAs), –143.2 (septet, 1 P, PF6)
ppm. ESI MS: m/z = 765.1 [M – H2O]+.
cis,mer-RuCl2(dmso-S)(PTA)3 (6): Complex 1 (30.0 mg,
0.038 mmol) was partially dissolved in DMSO (1 mL), and the mix-
ture was warmed to 70 °C whilst stirring. After 2 h of reaction,
the residual unreacted 1 was removed by filtration. The dropwise
addition of acetone to the mother liquor induced the formation of
a pale yellow precipitate within 24 h. The precipitate was removed
by filtration, washed with diethyl ether, and dried in vacuo. Accord-
ing to the 1H and 31P NMR spectra, the product was a mixture of 6
and 2 in an approximate ration of 40:60 (yield: 9 mg, 33 %). 1H
NMR (CDCl3): δ = 3.20 (s, 6H, dmso-S) ppm; in the PTA region, the
resonances of 2 and 6 overlap to such an extent that those of 6
could not be distinguished. 31P NMR (CDCl3): δ = –25.6 (t, 2JP,P =
27.9 Hz, 1 P, PTA trans to Cl), –61.0 (d, 2 P, mutually trans PTAs) ppm.
trans,mer-RuCl2(CH3CN)(PTA)3 (7) and cis,mer-RuCl2(CH3CN)-
(PTA)3 (8): Complex 1 (60.0 mg, 0.075 mmol) was partially dissolved
in acetonitrile (8 mL), and the mixture was heated under reflux for
2 h. Upon heating, 1 dissolved completely, the originally yellow
solution became progressively paler, and a pale yellow solid began
to form after ca. 1 h. After cooling to room temperature, the prod-
uct was collected by filtration, washed with acetonitrile and diethyl
ether, and dried in vacuo. According to the 1H and 31P NMR spectra,
the product was a mixture of 7, 8, and 1 in an approximate ratio
of 68:17:15 (yield: 15 mg, 29 %). 1H NMR (CDCl3): complexes 7 and
8: δ = 4.45 (m, NCH2N), 4.04 (br. s, NCH2P), 2.46 (s, 3H, CH3CN of 8),
2.30 (s, 3H, CH3CN of 7) ppm; it was not possible to distinguish the
PTA resonances of 7 and 8. 31P NMR (CDCl3): complex 7: δ = –16.1
(t, 1 P, 2JP,P = 28.5 Hz, PTA trans to CH3CN), –53.3 (d, 2 P, mutually
trans PTAs) ppm; complex 8: δ = –24.0 (t, 2JP,P = 37.2 Hz, 1 P, PTA
trans to Cl), –54.3 (d, 2 P, mutually trans PTAs) ppm.
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mer-[Ru(bpy)Cl(PTA)3]Cl (9): Complex 1 (40.0 mg, 0.050 mmol) was
dissolved in water (5 mL). 2,2′-Bipyridine (8.2 mg, 0.050 mmol) was
added, and the light-protected mixture was heated under reflux for
1 h. The yellow solution turned rapidly orange. The solvent was
removed by rotary evaporation to afford a yellow solid that was an
approximately equimolar mixture of free PTA and 9 with PTAO as
an impurity (less than 5 % of PTA) on the basis of the 1H and 31P
NMR spectra. X-ray quality crystals of 9 were obtained by the slow
diffusion of acetone into a water solution of the complex.
C28H44Cl2N11P3Ru·6H2O (907.70): calcd. C 37.05, H 6.22, N 16.97;
found C 36.87, H 6.03, N 16.87. Larger amounts of pure complex for
NMR spectroscopy characterization were obtained of the PF6 salt
(9PF6): the raw material (48.1 mg) was dissolved in water (1 mL)
and a solution (1 mL) of NaPF6 (12.5 mg, 0.075 mmol) was added.
The yellow crystals that formed in a few hours were collected by
filtration and dried in vacuo (yield: 28.1 mg, 62 %). The product was
pure 9PF6 according to the 1H and 31P NMR spectra. 1H NMR (D2O):
δ = 9.45 (d, 1 H, 6-H), 8.65 (d, 1 H, 3-H), 8.55 (d, 1 H, 3′-H), 8.41 (m,
2 H, 4-H + 6′-H), 8.18 (t, 1 H, 4′-H), 7.94 (t, 1 H, 5-H), 7.58 (t, 1 H, 5′-
H), 4.93, 4.85 (AB q, JA,B = 13.1 Hz, 6 H, NCH2N, PTA trans to N), 4.52
(br. s, 6 H, NCH2P, PTA trans to N), 4.54, 4.45 (AB q, JA,B = 13.9 Hz,
12 H, NCH2N, mutually trans PTAs), 3.72 (br. s, 12 H, NCH2P, mutually
trans PTAs) ppm. 13C NMR (partial, HSQC, D2O): δ = 156.2 (C-6′),
150.7 (C-6), 146.8 (C-4), 138.9 (C-4′), 128.2 (C-5′), 127.3 (C-5), 125.6
(C-3′), 124.9 (C-3), 70.7 (NCH2N, PTA trans to N), 70.5 (NCH2N, mutu-
ally trans PTAs), 52.2 (NCH2P, PTA trans to N), 46.6 (NCH2P, mutually
trans PTAs) ppm. 31P NMR (D2O): δ = –30.2 (t, 2JP,P = 32.8 Hz, 1 P,
PTA trans to N), –47.6 (d, 2 P, mutually trans PTAs), –144.4 (septet,
PF6) ppm. ESI MS: m/z = 764.2 [M]+, 607.2 [M – PTA]+. UV/Vis (H2O):
λmax (ε, L mol–1 cm–1) = 390 (1310) nm.
fac-[Ru(bpy)Cl(PTA)3]Cl (10): Complex 2 (45.0 mg, 0.056 mmol)
was dissolved in water (8 mL). 2,2′-Bipyridine (43.9 mg, 0.280 mmol)
and AgNO3 (9.6 mg, 0.056 mmol) were added, and the light-pro-
tected mixture was heated under reflux for 1 h. The yellow solution
turned rapidly orange, and a grey precipitate of AgCl formed. The
mixture was filtered through a pad of Celite, and the solvent was
removed from the clear solution by rotary evaporation to afford a
yellow solid, which, according to the 1H and 31P NMR spectra, was
a mixture of 9 and 10 in a 1:7 ratio. No residual 2 was present. The
pure fac isomer for full characterization was obtained as a PF6 salt
(10PF6): the raw mixture (87.3 mg) was dissolved in water (1 mL),
and a solution (1 mL) of NaPF6 (18.6 mg, 0.11 mmol) was added.
The yellow microcrystalline solid that formed within a few hours at
room temperature was collected by filtration, washed with cold wa-
ter, and dried in vacuo (yield: 14.1 mg, 31 %). The product was pure
10PF6 according to the 1H and 31P NMR spectra. Low-quality single
crystals of fully protonated 10, as fac-[Ru(bpy)Cl(PTAH)3][0.5Cl]-
[3.5ClO4], were obtained through the addition of a 0.5 M solution
of HClO4 to a water solution of the complex and used for X-ray
diffraction analysis. Complex 10PF6: C28H44ClF6N11P4Ru (909.13):
calcd. C 36.99, H 4.88, N 16.95; found C 37.18, H 4.90, N 17.03. 1H
NMR (D2O + NaCl): δ = 8.99 (br. s, 2 H, 6-H), 8.54 (d, 2 H, 3-H), 8.29
(t, 2 H, 4-H), 7.80 (t, 2 H, 5-H), 4.65 (m, partially overlapped by the
water signal, 12 H, NCH2N, PTA trans to N), 4.49 (m, partially over-
lapped by the singlet at 4.44, 6 H, NCH2N, PTA trans to Cl), 4.44 (s,
12 H, NCH2P, PTA trans to N), 3.88 (s, 6 H, NCH2P, PTA trans to Cl)
ppm. 13C NMR (partial, HSQC, D2O): δ = 154.5 (C-6), 140.3 (C-4),
126.5 (C-5), 124.7 (C-3), 70.7 (NCH2N, PTA trans to Cl), 70.5 (NCH2N,
PTA trans to N), 52.2 (NCH2P, PTA trans to Cl), 46.6 (NCH2P, PTA trans
to N) ppm. 31P NMR (D2O): δ = –24.3 (t, 2JP,P = 29.2 Hz, 1 P, PTA
trans to Cl), –43.1 (d, 2 P, PTA trans to N), –144.4 (septet, 1 P, PF6)
ppm. Complex 10aq: 1H NMR (D2O): δ = 8.95 (br. s, 2 H, 6-H), 8.58
(d, 2 H, 3-H), 8.33 (t, 2 H, 4-H), 7.83 (t, 2 H, 5-H), 4.65 (m, 12H,
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NCH2N), 4.46 (s, 12H, NCH2P), 4.43 (m, 6H, NCH2N, PTA trans to OH2),
3.84 (s, 6H, NCH2P, PTA trans to OH2) ppm; it was not possible to
distinguish the PTA resonances of 10 and 10aq. 31P NMR (D2O): δ =
–17.7 (t, 1 P, 2JP,P = 30.2 Hz, PTA trans to OH2), –43.5 (d, 2 P, PTA
trans to N), –144.4 (septet, 1 P, PF6) ppm. ESI MS: m/z = 764.2 [M]+,
607.2 [M – PTA]+. UV/Vis (H2O): λmax (ε, L mol–1 cm–1) = 385 (2385)
nm.
cis,cis,trans-RuCl2(dmso-S)2(PTA)2 (12): A different procedure to
that reported by Kathó and co-workers was followed.[11] Complex
11 (340 mg, 0.70 mml) was partially dissolved in methanol (5 mL).
A solution of PTA (220 mg, 1.4 mmol) in methanol (10 mL) was
added dropwise over 15 min. A pale yellow solid began to form
after a few minutes. The reaction was left to stand overnight, and
the product was collected by filtration, washed with methanol and
diethyl ether, and dried in vacuo (yield: 357 mg, 80 %). According
to the 1H and 31P NMR spectra, the product was pure 12. X-ray
quality crystals of 12 were obtained by the slow diffusion of
diethyl ether into a methanol solution of the complex.
C16H36N6Cl2P2S2OsRu (642.55): calcd. C 29.91, H 5.65, N 13.08; found
C 29.99, H 5.60, N 13.15. 1H NMR (D2O): δ = 4.51 (br. s, 12 H, NCH2N),
4.32 (br. s, 12 H, NCH2P), 3.38 (s, 12 H, dmso-S) ppm. 31P NMR (D2O):
δ = –57.9 (s) ppm. 1H NMR (CDCl3): δ = 4.52, 4.47 (AB q, JA,B =
13.0 Hz, 12 H, NCH2N), 4.41 (br. s, 12 H, NCH2P), 3.32 (s, 12 H, dmso-
S) ppm. 13C NMR (CDCl3): δ = 73.1 (NCH2N), 51.3 (NCH2P), 51.1
(dmso-S) ppm. 31P NMR (CDCl3): δ = –63.5 (s) ppm. ESI MS: m/z =
643.0 [M]+.
cis,cis-Ru(bpy)Cl2(PTA)2 (16): Complex 12 (70.0 mg, 0.109 mmol)
was partially dissolved in ethanol (10 mL). 2,2′-Bipyridine (34.0 mg,
0.218 mmol) was added, and the mixture was heated under reflux
for 6 h. The clear solution obtained gradually become ruby red
upon warming, and a precipitate of the same color began to form
after 4 h. The mixture was concentrated to ca. 3 mL and left to
stand overnight at room temperature, and the precipitate was col-
lected by filtration, washed with diethyl ether, and dried in vacuo
(yield: 42.0 mg, 54 %). According to the 1H and 31P NMR spectra,
the product was pure 16. X-ray quality crystals of 16 were obtained
by the slow diffusion of diethyl ether into a methanol solution of
the complex. C22H32Cl2N8P2Ru (642.46): calcd. C 41.13, H 5.02, N
17.44; found C 41.16, H 5.00, N 17.45. 1H NMR (CDCl3): δ = 9.88 (d,
1 H, 6-H bpy), 8.55 (d, 1 H, 6′-H bpy), 8.10 (d, 1 H, 3-H bpy), 8.04 (d,
1 H, 3′-H bpy), 7.95 (t, 1 H, 4-H bpy), 7.78 (t, 1 H, 4′-H bpy), 7.58 (t,
1 H, 5-H bpy), 7.20 (t, 1 H, 5′-H bpy), 4.64 (s, 6 H, NCH2N, PTA trans
to N), 4.60, 4.53 (AB q, JA,B = 15.0 Hz, 6 H, NCH2P, PTA trans to N),
4.39, 4.19 (AB q, JA,B = 13.0 Hz, 6 H, NCH2N, PTA trans to Cl), 3.70,
3.59 (AB q, JA,B = 15.1 Hz, 6 H, NCH2P, PTA trans to Cl) ppm. 13C
NMR (partial, HSQC, CDCl3): δ = 156.7 (C-6′), 151.1 (C-6), 136.9 (C-
4), 135.2 (C-4′), 125.8 (C-5), 125.2 (C-5′), 122.9 (C-3′), 121.7 (C-3),
73.31 (NCH2N, PTA trans to N), 72.0 (NCH2N, PTA trans to Cl), 54.0
(NCH2P, PTA trans to N), 53.2 (NCH2P, PTA trans to Cl) ppm. 31P NMR
(CDCl3): δ = –21.6 (d, 2JP,P = 34.4 Hz, 1 P, PTA trans to Cl), –36.2 (d,
1 P, trans to N) ppm. 1H NMR (D2O): complex 16aq: δ = 9.51 (d, 1 H,
6-H bpy), 8.53 (d, 1 H, 6′-H bpy), 8.49 (d, 1 H, 3-H bpy), 8.42 (d, 1 H,
3′-H bpy), 8.27 (t, 1 H, 4-H bpy), 8.09 (t, 1 H, 4′-H bpy), 7.80 (t, 1 H,
5-H bpy), 7.50 (t, 1 H, 5′-H bpy), 4.66 (s, 6 H, NCH2N, PTA trans to
N), 4.45 (s, 6H, NCH2P, PTA trans to N), 4.38, 4.27 (AB q, 6H, JA,B =
13.3 Hz, NCH2N, PTA trans to OH2), 3.66 (m, 6H, NCH2P, PTA trans to
OH2) ppm. 31P NMR (D2O): δ = –7.0 (d, 2JP,P = 37.7 Hz, PTA trans to
OH2), –31.9 (d, PTA trans to N) ppm. 1H NMR: (D2O + NaCl): complex
16: δ = 9.45 (d, 1 H, 6-H bpy), 8.55 (m, 1 H, 6′-H bpy), 8.44 (d, 2 H,
3-H and 3′-H), 8.22 (t, 1 H, 4-H bpy), 8.02 (t, 1 H, 4′-H bpy), 7.75 (t,
1 H, 5-H bpy), 7.45 (t, 1 H, 5′-H bpy), 4.38 (m, 12H, NCH2N), 3.65
(m, 12H, NCH2P) ppm; it was not possible to distinguish the PTA
resonances of 16 and 16aq. 31P NMR (D2O + NaCl): δ = –12.7
Eur. J. Inorg. Chem. 2016, 2850–2860 www.eurjic.org © 2016 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim2859
(d, 2JP,P = 37.1 Hz, 1 P, PTA trans to Cl), –33.8 (d, 1 P, PTA trans to N)
ppm. ESI MS: m/z = 607.0 [M – Cl]+. UV/Vis (H2O): λmax (ε,
L mol–1 cm–1) = 412 (2839) nm.
cis,cis-Ru(bpyAc)Cl2(PTA)2 (17): Complex 12 (50.0 mg,
0.078 mmol) was partially dissolved in ethanol (15 mL). 4′-Methyl-
2,2′-bipyridine-4-carboxylic acid (bpyAc, 33.4 mg, 0.156 mmol) was
added, and the mixture was heated under reflux for 6 h. The clear
solution obtained gradually became deep red upon warming. As
the solution cooled to room temperature, a red powder precipi-
tated. The red powder was collected by filtration, washed with eth-
anol and diethyl ether, and dried in vacuo (yield: 20.0 mg, 37 %).
According to the 1H and 31P NMR spectra, the product was pure
17, as a nearly equimolar mixture of the two stereoisomers 17a
and 17b. C24H34Cl2N8O2P2Ru (700.5): calcd. C 41.15, H 4.39, N 16.00;
found C 41.05, H 4.33, N 15.95. 1H NMR (D2O): complex 17aq: δ =
9.58 (d, 1 H, 6-H 17aaq), 9.31 (d, 1 H, 6′-H 17baq), 8.74 (s, 1 H, 3-H
17aaq), 8.67 (s, 1 H, 3-H 17baq), 8.57 (d, 1 H, 6-H 17baq), 8.42 (s, 1
H, 3′-H 17baq), 8.36 (s, 1 H, 3′-H 17aaq), 8.32 (d, 1 H, 6′-H 17aaq),
8.06 (d, 1 H, 5-H 17aaq), 7.76 (d, 1 H, 5-H 17baq), 7.68 (d, 1 H, 5′-H
17baq), 7.39 (d, 1 H, 5′-H 17aaq), 4.84 (br. s, 12 H, NCH2N, PTA trans
to N), 4.54 (br. s, 12 H, NCH2P, PTA trans to N), 4.43 (m, 12 H, NCH2N,
PTA trans to OH2), 3.77, 3.72 (AB q, 12 H, NCH2P, JA,B = 14.7 Hz, PTA
trans to OH2), 2.64 (s, 3H, CH3 17baq), 2.56 (s, 3 H, CH3 17aaq) ppm;
the PTA resonances of 17aaq and 17baq overlapped and could not
be distinguished. 13C NMR (partial, HSQC, D2O): complex 17aq: δ =
157.7 (C-6 17baq), 156.4 (C-6′ 17aaq), 150.7 (C-6 17aaq), 149.2 (C-6′
17baq), 128.3 (C-5′ 17aaq), 127.8 (C-5′ 17baq), 125.5 (C-5 17baq),
125.1 (C-5 17aaq), 124.7 (C-3′ 17baq), 123.1 (C-3 17baq), 122.5 (C-3
17aaq), 125.7 (C-3′ 17aaq), 70.5 (NCH2N, PTA trans to N), 70.5 (NCH2N
PTA trans to OH2), 49.9 (NCH2P, PTA trans to OH2), 49.5 (NCH2P, PTA
trans to N), 21.0 (CH3 17baq), 20.0 (CH3 17aaq) ppm; the PTA reso-
nances of 17aaq and 17baq overlapped and could not be distin-
guished. 31P NMR (D2O): complex 17aq: δ = –4.0 (m, 4 P, PTA trans
to OH2), –26.0 (m, 4 P, PTA trans to N) ppm. 31P NMR (D2O + NaCl):
complex 17: δ = –9.5 (m, 4 P, PTA trans to Cl), –25.4 (m, 4 P, PTA
trans to N) ppm. ESI MS: m/z = 665.2 [M – Cl]+. UV/Vis (H2O): λmax
(ε, L mol–1 cm–1) = 412 (1615) nm.
CCDC 1449210 (for 9), 1449211 (for 10), 1449212 (for 12), and
1449213 (for 16) contain the supplementary crystallographic data
for this paper. These data can be obtained free of charge from The
Cambridge Crystallographic Data Centre.
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